To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB Pharma
• Treatments: Lacosamide

Criteria

Inclusion Criteria:

• Completion of parent clinical trial for treatment of partial seizures.

Exclusion Criteria:

• Receiving any study drug or experimental device other than lacosamide.

• Meets withdrawal criteria for parent trial or experiencing ongoing serious adverse event.